Effects of neopluramycin on ascites tumors implanted in experimental animals.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D007274:Injections, Intraperitoneal; D007938:Leukemia / Q000188:drug therapy; D008113:Liver Neoplasms; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats
D000903:Antibiotics, Antineoplastic; D003630:Daunorubicin